In summary, studies in vitro and in mice suggest that inhibiting the canonical Wnt/β-catenin signaling pathway, especially through increased expression of its antagonists like sclerostin, is an important factor contributing to glucocorticoid-induced osteoporosis. This evidence concerns the gene SOST and osteoporosis.